NCT03976245 2024-11-29
Advanced Therapeutics in Rheumatoid Arthritis (RA)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 4 Recruiting
Clinical Trials
8 trialsNCT01793519 2024-02-28
STARA
Georgetown University
Phase 4 Unknown
NCT00837434 2021-09-22
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 4 Completed
NCT02092467 2021-08-17
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Pfizer
Phase 4 Completed
NCT00357903 2017-02-09
Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials
Amgen
Phase 3 Completed
NCT02109289 2017-02-07
Etanercept in Rheumatoid Arthritis and Vascular Inflammation
Innovaderm Research Inc.
Phase 4 Terminated
NCT01295151 2016-11-02
SWITCH
University of Leeds
Phase 4 Completed
NCT01009879 2013-07-02
Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants
University of Pittsburgh
Phase 4 Withdrawn